Cita APA

Fujita, M., Abe, K., Hayashi, M., Takahashi, A., & Ohira, H. (2020). Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. Medicine (Baltimore).

Chicago Style Citation

Fujita, Masashi, Kazumichi Abe, Manabu Hayashi, Atsushi Takahashi, i Hiromasa Ohira. "Skeletal Muscle Volume Loss Among Liver Cirrhosis Patients Receiving Levocarnitine Predicts Poor Prognosis." Medicine (Baltimore) 2020.

Cita MLA

Fujita, Masashi, et al. "Skeletal Muscle Volume Loss Among Liver Cirrhosis Patients Receiving Levocarnitine Predicts Poor Prognosis." Medicine (Baltimore) 2020.